XLF News 22.83 06/23/2014 05:41:41 Financial Select Sector SPDR

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Financial Select Sector SPDR (XLF) 22.83 $XLF

Powerhouse ETFs: Transports and Technology Are the Best Performers
at The Street - Thu Jun 12, 10:58AM CDT
I continue to track 11 Exchange Traded Funds as a conservative way to invest in specific sectors of the stock market in an environment where stock-picking remains difficult.

Wall Street Bulls Salvage a Win
at The Street - Fri May 16, 4:19PM CDT
After trading most of Friday in the red, the indexes were able to close higher.

What is Driving Bank ETFs Lower? - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu May 15, 9:01AM CDT
Financial ETFs in the banking world have been hit hard lately, what is behind this slump?

Powerhouse ETFs: Energy, Consumer Staples and Utilities Outperform
at The Street - Mon May 12, 12:03PM CDT
There are 11 Exchange Traded Funds that provide a conservative way to invest in specific sectors without the risk of stock picking.

Insurance ETFs Crushing Financials on Q1 Earnings - ETF News And Commentary
Sweta Killa - ZACKS - Fri May 09, 1:00PM CDT
Insurance ETFs are leading the financial ETF space in the trailing one-month period on decent earnings.

Banking Sector Earnings Put These Financial ETFs in Focus - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 9:00AM CDT
Thanks to some big banks reporting as of late, these financial ETFs look to be in focus.

Utilities, Health Care Leading ETF Sectors
at The Street - Wed Apr 02, 9:15AM CDT
Here are some investments to get exposure to broad sectors in the economy.

March ETF Report: U.S. Equities Thrive, Emerging Markets Suffer - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Apr 02, 9:00AM CDT
These ETFs saw the biggest inflows and outflows for March 2014.

3 Dirt Cheap Top Ranked ETFs to Buy Now - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Mar 31, 12:00PM CDT
These ultra cheap ETFs could be solid investments for those looking for long term plays.

3 Financial ETFs to Play the Bank Stress Tests - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 9:00AM CDT
These financial ETFs look to be in focus following the recent bank stress tests.

First Week Of XLF July 19th Options Trading
at The Street - Wed Mar 26, 11:19AM CDT
Investors in Financial Select Sector SPDR Fund saw new options begin trading this week, for the July 19th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 115 days until...

Roundtable Top Picks for the Week of Mar. 24th - Video Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 24, 3:52PM CDT
Ideas for Auto Parts, Financials and Pharmaceuticals. Opportunities covered include Motorcar Parts of America, Inc. (MPAA), Financial Select Sector SPDR Fund (XLF) and Horizon Pharmaceutical (HZNP).

Play Rising Rates with These ETFs - ETF News And Commentary
Sweta Killa - ZACKS - Fri Mar 21, 11:00AM CDT
Financials ETFs would be the main beneficiary of a rising interest rates environment.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 445

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 410

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
AutoShop Answers Extends 2027 Training Into Fridays

Updated Category News Views 55

A repair bay can hum all day while the back office quietly bleeds profit. That unglamorous reality is why AutoShop Answers adding nine Friday specialty classes to its 2027 Key2Key Weekend calendar deserves a closer look. This is not a new tool chest or some vague motivational roadshow; it is an attempt to give independent shop owners an extra day to work on the pieces...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading

Top 5 Most Recently Viewed Articles

Regulatory T-Cells Market Growth Driven by New Therapies

Updated Category News Views 217

Insights into the Regulatory T-Cells Market Growth The landscape of the Treg therapy market is rapidly evolving as companies globally actively develop innovative regulatory T-cell therapies to treat various critical conditions. These include systemic lupus erythematosus (SLE), lupus nephritis, atopic dermatitis, rheumatoid arthritis, psoriasis, progressive multiple...

Continue Reading
Natural Grocers Unveils Autumnfest Super Savings Event

Updated Category News Views 67

Natural Grocers Introduces Autumnfest Savings Event As the autumn leaves begin to fall, Natural Grocers invites shoppers to revel in the festivities of the season with their exciting Autumnfest Savings Event. This annual celebration promises customers an incredible opportunity to enjoy significant discounts, free samples, and delightful seasonal recipes. With savings of...

Continue Reading
Anthem Blue Cross Commits $10 Million for Wildfire Relief

Updated Category News Views 270

Anthem Blue Cross Generously Assists Communities Affected by Wildfires For over eight decades, Anthem Blue Cross has maintained a strong presence in California, prioritizing the health and well-being of its residents. Our focus has always been on putting people first, as we acknowledge the struggles that come with disasters that can significantly impact the lives of our...

Continue Reading
Corporate Legal Departments Face Major Workforce Challenges

Updated Category News Views 179

Corporate Legal Departments Face Major Workforce Challenges In the evolving landscape of corporate legal departments, a significant wave of attrition is looming as in-house attorneys express a desire to seek better opportunities. The increase in workloads, coupled with concerns about artificial intelligence and limited career advancement prospects, has prompted many legal...

Continue Reading
Currax Achieves FDA Approval for Enhanced CONTRAVE Supply Chain

Updated Category News Views 411

Currax Expands Manufacturing Capabilities for CONTRAVE Currax Pharmaceuticals LLC, a focused specialty pharmaceutical company, recently announced a significant milestone in its operations. The U.S. Food and Drug Administration (FDA) has granted approval for a second manufacturing facility dedicated to the production of CONTRAVE (naltrexone HCl/bupropion HCl), a leading...

Continue Reading